newswire, breaking biotechnology and pharma news

Wednesday, September 26, 2012

Biotech Stock Trading Alert: Sunshine Biopharma (OTCBB: SBFM) Gains

New York, New York - September 26, 2012 ( Newswire,, an investor research portal specializing in sector research including biotech and pharma stocks issues a trading alert for Sunshine Biopharma Inc. (OTCBB: SBFM) . The stock is trading at $ 0.31, up 0.03 or 10.71% as of 1:42PM EDT on over 86,000 shares, with a day high of $0.34.
The Company reported news yesterday that that its paper on Adva-27a preclinical research results has been accepted and will be published in the October issue of ANTICANCER RESEARCH, a peer-reviewed International Journal of Cancer Research and Treatment.
Full news: Newswire About Sunshine Biopharma Inc. (OTCBB: SBFM):
Sunshine Biopharma is a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer. The Company's lead compound, Adva-27a targets aggressive forms of cancer.
About is a leader in investor stock research by sector, including biotech and pharma stocks. Visit the biotech portal within Investor Ideas:
Follow on Twitter!/Investorideas
Follow on Facebook
Sign up for the free investor news and biotech stock alerts
Disclaimer/ Disclosure : The is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: A third party on behalf of SBFM compensated for news release publishing and distribution: one hundred thousand 144 shares for three months starting June 26 th
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info:
800-665-0411 - Source -

1 comment:

  1. These chart is more helpful, as well as understandable, there are lot of ways to represent the report, the graph is the best way to represent the chart, i understand these chart. Generic Viagra